Halo Biosciences
Phase 2Modulating the extracelluar matrix (ECM) to transform inflammatory and fibrotic diseases
Founded
2015
Focus
Small Molecules
About
Modulating the extracelluar matrix (ECM) to transform inflammatory and fibrotic diseases
Funding History
2Total raised: $17.5M
Series A$15MSofinnova PartnersNov 15, 2022
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationSan Diego, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile